Globus Medical Inc
NYSE:GMED
Globus Medical Inc
NYSE:GMED
Price:
64.72 USD
0.56%
Market Closed
Updated:
May 11, 2024
P/E
Price to Earnings
Price to Earnings
71.8
Current
43
Median
23.9
Industry
Higher
than median
Higher
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=71.8
Market Cap
/
8.8B
Net Income
122.9m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
|
Globus Medical Inc
NYSE:GMED
|
8.8B USD | 71.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182.2B USD | 32.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
137.2B USD | 69 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.9B USD | 37.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.1B USD | 26.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
108.3B USD | 61.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.1B USD | 55.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
58.7B EUR | 38.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52.2B USD | 36.9 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.5B CNY | 30.3 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.3B USD | 78.7 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
23.8
2-Years Forward
P/E
19.5
3-Years Forward
P/E
16.3
You don't have any saved screeners yet
